Each dose of gazyva is 1000 mg administered intravenously according to table 2 Patients who achieve stable disease, complete response, or partial response to the initial 6 cycles of gazyva treatment in combination with bendamustine should continue on gazyva 1000 mg as monotherapy for two years. During obinutuzumab and chemotherapy treatment, adjust the dosing schedule accordingly to maintain the time interval between chemotherapy cycles During monotherapy, maintain the original dosing schedule for subsequent doses. Gazyva, in combination with chlorambucil, is indicated for the treatment of patients with previously untreated chronic lymphocytic leukemia. Throughout the second month, you will gradually build up to a higher dose of venclexta and receive gazyva once during the month
If a planned dose of gazyva is missed, administer the missed dose as soon as possible During gazyva and chemotherapy treatment, adjust the dosing schedule accordingly to maintain the time interval between chemotherapy doses. Learn about how gazyva® (obinutuzumab) is administered and the dosing schedule for relapsed or refractory follicular lymphoma
OPEN
